Skip to main content
Clinical Trials/NL-OMON27596
NL-OMON27596RecruitingNot Applicable

Evaluation of a clinical prototype near-infrared fluorescence (NIRF) imaging device for detection of lymph node (LN) metastases in cervical cancer: a technical feasibility study.

MCG0 sites10 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
10

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Female > 21 years of age;
  • 2. Operable cervical cancer stage IAI, IBI or IIA.

Exclusion Criteria

  • 1. Renal, cardiac or pulmonary failure (ASA III-IV);
  • 2. Pregnancy;

Investigators

Sponsor
MCG

Similar Trials

Intra-operative imaging of lymph node... | Clinical Trial